Amniotic fluid Δ OD 450 values accurately predict severe fetal anemia in D-alloimmunization

Obstetrics and Gynecology

Volumn 100, Issue 1, 2002, Pages 51-57

  Sikkel, Esther ^a   Vandenbussche, Frank P H A ^a   Oepkes, Dick ^a   Meerman, Robertjan H ^a   Le Cessie, Saskia ^a   Kanhai, Humphrey H H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ALLOIMMUNIZATION; AMNION FLUID; ANEMIA; ARTICLE; CALCULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FETUS; GESTATIONAL AGE; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; STANDARD;

ADULT; AMNIOCENTESIS; AMNIOTIC FLUID; CONFIDENCE INTERVALS; ERYTHROBLASTOSIS, FETAL; FEMALE; FETAL DEATH; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RH ISOIMMUNIZATION; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036294338     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(02)01994-4     Document Type: Article

References (35)

1. Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization
2. Intrauterine transfusion utilizing ultrasound
3. Severe Rh disease - Poor outcome is not inevitable
4. Changes in the management of severely Rh-immunized patients
5. Does midtrimester delta OD450 of amniotic fluid reflect severity of Rh disease?
6. Amniotic fluid bilirubin as a prognostic indicator in rhesus isoimmunization
7. Six years’ experience of the prediction of severity in rhesus haemolytic disease
8. Liquor bilirubin levels and false prediction of severity in rhesus haemolytic disease
9. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks’ gestation: A proposal for clinical management
10. Intrauterine transfusion in the management of severe rhesus isoimmunization
11. A three-year assessment of an action line method of timing intervention in rhesus isoimmunization
12. Have Liley charts outlived their usefulness?
13. Serial fetal blood sampling for the management of pregnancies complicated by severe rhesus (D) isoimmunization
14. Assessment of the clinical usefulness of the ‘Queenan’ chart versus the ‘Liley’ chart in predicting severity of rhesus iso-immunization
15. Ultrasound in the evaluation and management of the isoimmunized pregnancy
16. Erythropoietic suppression in fetal anemia because of Kell alloimmunization
17. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia
18. High-dose intravenous IgG for the treatment of severe rhesus alloimmunization
19. Amniotic fluid bilirubin and fetal hemolytic disease
20. The use of ultrasonography and Doppler in the prediction of fetal haemolytic anaemia: A multivariate analysis
21. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses
22. Prospective non-invasive monitoring of pregnancies complicated by red cell alloimmunization
23. Systematic antenatal functional evaluation in pregnancies at risk of progressive fetal anemia
24. Middle cerebral artery peak systolic velocity in the prediction of fetal anemia
25. Management of severe hemolytic disease with ultrasound-guided intravascular fetal transfusions
26. The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions
27. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation
28. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment
29. Can a single measurement of amniotic fluid delta optical density be safely used in the clinical management of Rhesus-alloimmunized pregnancies before 27 weeks’ gestation?
30. Benefits and risks of fetal red-cell transfusion after 32 weeks’ gestation
31. The management of Rh-Isoimmunization
32. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women
33. Transplacental fetal hemorrhage after amniocentesis
34. Fetomaternal hemorrhage following funipuncture: Increase in severity of maternal red-cell alloimmunization